Orchid Pharma (ORCHPHARMA) Share News & Alerts

Orchid Pharma rises after Q4 net profit increases 7% to Rs 24 crore

▲ Bullish +13.79%

Orchid Pharma's Q4 net profit of Rs 24 crore meets the higher end of market expectations and breaks out from a sequence of consecutive net losses in the previous two quarters. This recovery in operating leverage and net margins provides a fundamentally backed technical trigger for a bullish swing over a multi-day to 2-3 week horizon. Given that the stock had underperformed its 52-week highs, this clear bottom-line turnaround acts as an immediate catalyst for price expansion as short-sellers cover and positional builders accumulation resumes.